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AB STRACT
Back ground/ Aim: Though there is an im prove ment in the di ag nos tics and treat ment of extrahepatic bile duct 
car ci noma (EHBDC) the post op er a tive re sults are still un sat is fac tory. The aim of the study was to ana lyse the
ex pe ri ence of the au thors’ in sti tu tion in the treat ment of EHBDC and to com pare the re sults ac cord ing to the
tu mor’s lo ca tion and stage and the sur gi cal pro ce dure per formed. Ma te rial and meth ods: From Jan.,1989 to
Jan.,2005, 1024 pa tients with EHBDC (incl. periampular ones)re ceived sur gi cal treat ment. The study was ret -
ro spec tive based on clin i cal, lab o ra tory, in stru men tal, intraoperative and patho log i cal data. Re sults: The
male/fe male ra tio was 3/2 and 44.53% of all pa tients were above 60 years of age. Most of the EHBDC’s were
lo cated in the dis tal part – 680 cases (66.41%). Klatskin tu mors ranked sec ond – 144 cases (14.06%). Rad i cal,
pal lia tive and explorative pro ce dures were per formed in 28.42%, 66.11% and 5.47% re spec tively. Rad i cal
resectability showed de pend ence on the tu mor’s lo ca tion and stage. The early mor bid ity and mor tal ity rates
were 31.84% and 14.16% re spec tively. The me dian long-term sur vival (in months) af ter rad i cal pro ce dures
was 24 for Klatskin tu mors, 17 for car ci noma of the mid dle EHBD and 40 for periampullary tu mors and these
fig ures were sig nif i cantly worse af ter pal li a tions. Con clu sions: 1. EHBDC is ob served more of ten in pa tients
above 60 years of age, it has ag gres sive bi ol ogy and poor prog no sis; 2. Re li abil ity of US, ERCP, CT-scan and
MRI in cases of EHBDC ex ceeds 95%; 3. More than 70% of the pa tients with EHBDC are di ag nosed in stage
III and IV lim it ing rad i cal resectability; 4. EHBDC’s of the mid dle and dis tal parts are more of ten suit able for
rad i cal re sec tions than prox i mal tu mors. 
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IN TRO DUC TION
The first def i ni tion of bile duct can cer is cred ited to Fardal
(1840). (1) But more than a cen tury af ter that G. Klatskin
(1963, New Ha ven, Con nect i cut) pub lished the first pro -
found and de tailed study on 13 cases of ma lig nant tu mors
of the prox i mal part of the extrahepatic biliary tree. (2) The
au thor de scribed this type of can cer as small, lo cal ized and
strictly con fined to the com mon hepatic duct, rarely
metastasizing, and in some cases lead ing to pu ru lent
cholangitis and/or acute hepatocellular fail ure. (2)
Now a days tu mors of the extrahepatic bile ducts (EHBD) are
clas si fied ac cord ing to their lo ca tion af ter W.P.Y. Longmire
(Fig.1). (3) The clas si fi ca tion of Bis muth and Cor lette is par -
tic u larly used for car ci no mas of the prox i mal part of the
EHBD – the so called “Klatskin” tu mors (Fig.2). (4)
The in ci dence rate of extrahepatic bile duct can cer
(EHBDC) in creases per ma nently dur ing the last three de -
cades but this might be a re sult of im proved di ag nos tics.
(1,5,6,11) Treat ment of EHBDC has also marked a prog -
ress due to ad vanced sur gi cal tech niques, en do scopic
biliary stenting, interventional ra di ol ogy and chemo- and
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Fig. 1. The classification of the main parts of the
extrahepattc bile ducts after WPY Longmire (1973)
ra di a tion ther apy.(1,7-17) How ever de spite these achieve -
ments EHBDC re mains a chal lenge to all the spe cial ist
from the multidisciplinary team dealing with this problem.
AIM
To study the ex pe ri ence of the au thors’ in sti tu tion in the di -
ag nos tics and treat ment of pa tients with EHBDC and to
ana lyse the early and late post op er a tive re sults and their de -
pend ence on the lo ca tion of the tu mor, its stage and the sur -
gi cal procedure performed.
MA TE RIAL AND METH ODS
From 01/01/1989 to 01/01/2005, 1024 con sec u tive pa tients 
with EHBDC in clud ing also periampullary tu mors were di -
ag nosed and treated at the Clinic of Gen eral, Liver and Pan -
cre atic Sur gery, Uni ver sity Hos pi tal “Alexandrovska”, So -
fia. The dis tri bu tion of cases ac cord ing to the lo ca tion of the 
pri mary tu mor is dem on strated on Table 1.
The study was ret ro spec tive based on di ag nos tic and sur gi -
cal meth ods and out pa tient fol low-up (once per three
months dur ing the first year and twice a year af ter that). Dif -
fer ences con cern ing mor bid ity and mor tal ity rates and
long-term sur vival were com pared us ing the chi-square test 
and Fisher’s ex act test. A “p”-value less than 0.05 was
considered significant. 
RE SULTS 
Among all the pa tients 619 (60.45%) were male and 405
(39.55%) fe male. The male/fe male ra tio was ap prox i -
mately 3/2 (p<0.001). The mean age of the whole group
was 60.7 +/- 18.3 years, 61.9 and 58.7 for men and women
re spec tively (p>0.05). The age above 60 years was the most 
of ten seen (44.53%) while only 23.73% of the pa tients
were un der 50 (p<0.01).
The anal y sis of data con cern ing the fre quency of dif fer ent
lo ca tions showed the prev a lence of periampullary tu mors -
680 cases (66.41%). Klatskin tu mors ranked sec ond with a
num ber of 144 cases (14.06%). Car ci noma of the mid dle
part of the EHBD was ob served in 53 pa tients (5.18%) and
to tal in volve ment of the EHBD in only 37 pa tients (3.61%)
(p<0,001).
The lead ing clin i cal symp toms and syn dromes (Ta ble 2)
and the lab o ra tory data (Table 3) were the typ i cal ones for
ma lig nant biliary ob struc tion. 
We used rou tinely ul tra sound (US), ERCP, com puted to -
mog ra phy (CT)-scan, mag netic res o nance (MR)
-cholangio-pancretaography and intraoperative
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Obstructive jaundice 981 95,80
Pain and dyscomfort in the right
hypochondium
868 84,76
Epigastric pain, nausea, vomitting 496 48,43
Weakness, loss of appetite and body 
weight
192 18,75
­T ° 171 16,70
Other nonspecific symptoms 98 9,57
Table 2. Clinical presentation of EHBDC
Location of the primary tumor No of cases %
Upper part of the EHBD
(Klatskin tumors)
144 14,06
Middle part of the EHBD 53 5,18
Periampulary tumors:
1. Distal common bile duct
2. Ampullary and papillary   
  tumors












Total involvement of the EHBD 37 3,61




Table 1. Relative frequency of the location of EHBDC
in our material
Fig. 2. The classification of Klatskin tumors after
Bismuth and Corlette (1975). Type I - common hepatic
duct; Type II - common hepatic duct + bifurcation;
Type III A - bifurcation + right hepatic duct; Type III Â
-bifurcation + left hepatic duct; Type IV - total
cholangiography for es tab lish ing the fi nal di ag no sis with a
high rate of re li abil ity, ex ceed ing 95% (Ta ble 4).
Rad i cal sur gi cal pro ce dures were re ceived by 291 pa tients
(28,42%), pal lia tive – by 677 pa tients (66,11%) and we
per formed only explorative laparotomies in 56 cases
(5,47%) (Ta ble 5). The type of the sur gi cal op er a tion cor re -
sponded to the stage of the EHBDC. The in stru men tal and
intraoperative data as well as the patho log i cal study
showed that 792 tu mors (77,34%) were in stage ²²² and ²V. 
Resectability de pended also to the lo ca tion of the car ci -
noma. Tu mors of the mid dle part of the EHBD were rad i -
cally re moved in 69.81% (37 from all the 53 cases) and tu -
mors of the dis tal com mon bile duct, the ampulla and the
pa pilla of Vater (i.e. periampullary tu mors ex clud ing pan -
cre atic and du o de nal can cer) – in 67.04% (59 from all the
88 cases).
There were 41 rad i cal re sec tions (22,05%) for Klatskin tu -
mors and 24 of them (16,66%) in cluded liver and/or vas cu -
lar re sec tions.
The to tal num ber of duodeno-pancreatectomies in cases of
periampullary tu mors was 193 (184 Whipple re sec tions
and 9 py lo rus pre serv ing Traverso-Longmire pro ce dures). 
The early post op er a tive mor tal ity rate was 14.16% (145
cases) in the whole group. It was higher in explorative
laparotomies – 28.57% (p<0,05). The main cause for fa tal
out come was pro gres sion of the hepatic dys func tion lead -
ing to hepatic failure.
The mor bid ity rate was 31.84% (326 cases). The most
com mon spe cific com pli ca tions were per sis tent
cholangitis, biliary leak age and acute up per gas tro in tes ti nal
tract bleed ing, ne ces si tat ing re-op er a tion in 23 cases
(2.25%). 
The me dian sur vival rates ac cord ing to the tu mor’s lo ca tion 
and the type of the sur gi cal pro ce dure are dem on strated on
Ta ble 6. The dif fer ences be tween these data af ter rad i cal
and pal lia tive op er a tions proved to be sta tis ti cally
significant (p<0.01). 
DIS CUS SION
The main char ac ter is tic fea tures of EHBDC are those de -
scribed by Klatskin. The tu mor ag gres sive ness is due to the
trend to vas cu lar in va sion and neu ral in fil tra tion but the ten -
dency to metastasise is lit tle and some times even pal li a tions 
may of fer a sat is fac tory long-term sur vival.
(1,7,8,10,11,19)
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Table 5. Types of the surgical procedures according to
the location of EHBDC
Method
Total No of investigations/











Klatskin tumors 24 4,9





*CBD -com mon bile duct
Table 6. Median survival according to the location of
the tumor and the type of the surgical procedure
Laboratory sign No of patients %
­ serum bilirubin 994 97,07
­ alkaline phosphatase 962 93,94
­ GGT 853 83,30%
­ ASAT; ­ ALAT 496 48,93
Secondary anaemia 704 68,75
Hypoalbuminemia 518 50,59
Disturbed coagulation 498 48,63
Table 3. Laboratory data in patients with EHBDC
The right ap proach to these cases and the way of ob tain ing
max i mum ben e fit and good qual ity of life are still con tro -
ver sial. Now we shall fo cus on some cur rent de bat able
prob lems con cern ing EHBDC.
Is it pos si ble to es tab lish the di ag no sis “EHBDC” early?
The clin i cal signs of EHBDC are more or less spe cific but
they are late. Tu mor mark ers (CA 19-9 and CEA) are of ten
nor mal (5,6). The di ag nos tics have been sig nif i cantly im -
proved due to the new meth ods rou tinely used in prac tice
dur ing the last 25-30 years - US, ERCP, CT and
MR-cholangiopancretaography. (6,8,11) How ever even
now a days about 70-75% of all cases are found in stage III
and IV which de ter mines the low rate of rad i cal
resectability and poor prog no sis. (7,11,14,18-20)
A pos si bil ity for early de tec tion of EHBDC ex ists in the ac -
tive out pa tient fol low-up of cases with a pre-can cer con di -
tion such as cys tic di la tion of the bile ducts, clonorchiasis,
hepatolithiasis, sclerosing cholangitis, va ri et ies of the
hepatic ar tery and its main branches caus ing com pres sion
on the EHBD. (6)
Rad i cal or pal lia tive pro ce dure should be pre ferred in
EHBDC?
Ac cord ing to the lit er a ture there is no agree ment yet about
the type of the sur gi cal pro ce dure. But any type of treat -
ment (sur gi cal or other) is man da tory since life ex pec tancy
ranges from 2 to 5 months with out a re lief of ob struc tive
jaun dice! (7)
Cri te ria of resectability are ob tained pre-op er a tively by the
triad “cholangiogram + CT and/or MRI + se lec tive
angiogram”. (6) Rad i cal pro ce dure can be achieved by sim -
ple bile duct re sec tion in a few cases. Most of them need
also a vas cu lar re sec tion and re con struc tion +/- liver re sec -
tion +/- DHPE in or der to be la beled “rad i cal”. (19)
Many au thors ad vo cate only pal li a tions in EHBDC by
point ing the lack of sig nif i cant dif fer ences be tween the re -
cur rence rates and me dian sur vival af ter rad i cal and pal lia -
tive op er a tions on the one hand and the early post op er a tive
mor bid ity and mor tal ity rates af ter rad i cal re sec tions are
dra mat i cally higher than af ter pal li a tions. (8,11,12)
Based on our ex pe ri ence we ap ply an in di vid ual ap proach
to ev ery case of EHBDC and make the fi nal de ci sion about
the type of the pro ce dure af ter the intraoperative ex plo ra -
tion – in spec tion, pal pa tion, in stru men tal (US,
cholangiogram, choledochoscopy) and histological in ves ti -
ga tion. We found sig nif i cant dif fer ences be tween the late
re sults af ter rad i cal and pal lia tive pro ce dures in our ma te rial 
(Ta ble 6). That’s why we aim to be rad i cal when ever pos -
si ble but with out tak ing se ri ous risks and pay ing at ten tion
to all the lim it ing fac tors such as: (a) lo cally ad vanced tu -
mors and/or dis tant metastases; (b) ad vanced age (above 70 
but this is n’t ab so lute) and poor gen eral con di tion of the pa -
tient (co-ex ist ing cardio-vas cu lar, re spi ra tory, he ma to log i -
cal and nephrological diseases); (c) severe jaundice – total
serum bilirubin > 350 µmol/l.
How should a pal lia tive pro ce dure be done?
En do scopic in ser tion of a biliary stent and interventional
ra dio log i cal pro ce dures (percutaneous ex ter nal biliary
drain age) of fer an al ter na tive to con ven tional sur gery. In
the be gin ning of 1980’s en do scopic biliary stenting (EBS)
was char ac ter ized by high mor bid ity and mor tal ity rates
and short me dian sur vival. (9,15) At pres ent EBS is char ac -
ter ized by: (a) suc cess ful in stal la tion and ef fec tive ness (re -
lease of jaun dice) in more than 90% of in di cated cases; (b)
du ra tion of ef fec tive ness - about 3 months for plas tic and
6-7 months for metal stents; (c) sur vival rates com pa ra ble
to those of sur gery, but this type of treat ment is much
cheaper and the me dian hos pi tal stay is shorter. (13,17)
In our prac tice we pre fer EBS only in cases of unresectable
ma lig nant biliary ob struc tion de tected pre op er a tively and
lack of duodenostasis which in di cates gas tro-jejunostomy. 
Are chemo- and ra di a tion ther apy in di cated in BDC?
Rescently most au thors em pha size on the fact that ap pro -
pri ate treat ment of EHBDC needs to be multidisciplinary
in clud ing chemo- and radiationtherapy. (14,16) How ever
there is no enough ex pe ri ence. Most of the re ports are on
sin gle cases or small se ries. Though the ini tial re sults are
prom is ing fur ther stud ies are nec es sary for mak ing final
conclusions. 
CON CLU SIONS
1. EHBDC is ob served more of ten in pa tients above 60
years of age, it has ag gres sive bi ol ogy and poor
prog no sis;
2. Re li abil ity of US, ERCP, CT-scan and MRI in cases of
EHBDC ex ceeds 95%. These meth ods are able to
an swer the ques tion whether there is or there is n’t
EHBDC quite sat is fac tory but they could n’t be used for 
early di ag no sis nei ther for screen ing. 
3. Most of the pa tients with EHBDC all over the world as
well as in Bul garia are di ag nosed lately - more than
70% in stage III and IV. This de ter mines the low
resectability rate and the un sat is fac tory late re sults –
post op er a tive sur vival of short me dian duration;
4. EHBDC’s of the mid dle and dis tal parts are more
suit able for rad i cal re sec tions than prox i mal and to tal
tu mors. 
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